Press Releases from KuicK Research (285 total)
Multispecific Antibodies Clinical Trials By Indication Country Company Drug Clas …
Global Multispecific Antibodies Market, Drug Sales, Dosage, Price and Clinical Trials Insight 2030 Report Highlights:
• Global Multispecific Antibodies Market Opportunity By 2030: > USD 50…
Gamma Delta T Cell Cancer Therapy Market Opportunity Clinical Trials Technology …
Global Gamma Delta T Cell Cancer Therapy Market Opportunity and Clinical Trials Insight 2030 Report Conclusions:
• Number Of Gamma Delta T Cell Therapies In Trials:…
US Orphan Drugs Market Sales Clinical Trials Insight 2030
US Orphan Designated Drugs Market Opportunity, Drugs Sales, Price, Dosage and Clinical Trials Insight 2030 Report Offering and Highlights:
• US Orphan Designated Drugs Market Opportunity: >…
US Orphan Drug Market Size Forecast 20230
US Orphan Designated Drugs Market Opportunity, Drugs Sales, Price, Dosage and Clinical Trials Insight 2030 Report Offering and Highlights:
• US Orphan Designated Drugs Market Opportunity:…
Molecular Switches Role As Therapeutic Targets In Drug Development
Molecular Switches As Therapeutic Targets, Drug Development, Drug Delivery Mechanism & Application By Indications Insight 2025 Research Insights:
• Top 20 Drugs Sales Targeting Molecular Switches:…
Targeted Alpha Therapy Clinical Trials Market Size Forecast 2028
Global Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028 Report Highlights:
• Global Targeted Alpha Therapy Market Insight By Region
•…
Saudi Arabia Clinical Trials Registry Drugs Market Database Insight
Saudi Arabia Clinical Trials Market, Ongoing Clinical Trials By Company, Indication, Phase & Regulations Insight 2025 Report Highlights:
• Saudi Arabia Clinical Trials Market Opportunity: US$…
PROTAC Cancer Therapy PROTAC Drugs Clinical Trials Insight
Global Proteolysis Targeting Chimeras PROTAC Therapy Clinical Trials Insight & Market Opportunity Report Highlights:
• First PROTAC Drug Approval Expected By 2027
• Insight On More Than 50 PROTAC…
Oncolytic Virus Therapy Clinical Trials FDA Approval Market Size Forecast
Global Oncolytic Virus Immunotherapy Market Opportunity & Clinical Trials Insight 2030 Report Highlights:
• Global Oncolytic Virus Immunotherapy Therapy Market Opportunity: > USD 1.50 Billion By 2030
• Oncolytic…
Brazil Clinical Trials Market ANVISA Brazil Guidelines Brazil Clinical Trials Re …
Brazil Cancer Drugs Clinical Trials Insight 2024 Report Offering:
• Brazil Clinical Trials Market Opportunity 2024 and 2030 (In US$ Billion)
• Clinical Trials Regulatory Framework In Brazil
• Total Number…
VISTA inhibitors Drugs Clinical Trials FDA Approval Market Opportunity Insight
Global VISTA Inhibitor Clinical Trials and Market Opportunity Insight 2024 Report Highlights:
• Global VISTA Inhibitors Clinical Trials Insight By Company, Country, Indication and Phase
• VISTA Inhibitors Clinical…
Trispecific Antibody Market Opportunity Outlook
Global Trispecific Antibodies Clinical Trials and Market Outlook 2024 Report Highlights:
• Trispecific Antibodies In Clinical Trials: > 50 Antibodies
• Majority Of Antibodies Developed For Multiple Myeloma: 8…
Global Multispecific Antibodies Market Size Antibodies Sales Forecast 2029
Global Multispecific Antibodies Market, Drug Sales, Price & Clinical Trials Insight 2029 Report Highlights:
• Global & Regional Market Analysis
• Global Multispecific Antibodies Market Opportunity: > USD 40…
Crisper Cas9 Cancer Therapy Clinical Trials Insight
Global CRISPR Cas9 Market Opportunity & Clinical Trials Outlook 2029 Report Offering:
• Global & Regional Commercial & Clinical Outlook
• Global CRISPR-Cas9 Therapy Clinical Trials By Company, County,…
TIGIT Antibody Clinical Trials FDA Approval Market Size Anti TGIT Antibody Sales …
Anti TIGIT Antibodies Clinical Trials & Market Opportunity Outlook 2028 Report Highlights:
• Anti TIGIT Antibodies In Clinical Trials: > 50 Antibodies
• First Anti TIGIT Antibody To Get…
MCL-1 Inhibitors Clinical Trials Approved Drugs FDA Approval Insight
MCL1 Inhibitor Drug Clinical Trials and Commercialization Opportunity Insights 2024 Report Highlights:
• Research Methodology
• ML1 Inhibitor Drug In Clinical Trials: > 10 Drugs
• MCL1 Inhibitor Drug Clinical Trials…
Global Bispecific Antibody Market Size Bispecific Antibodies Clinical Trials FDA …
Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights:
• Bispecific Antibodies Development Proprietary Platforms Insight: > 30 Platforms
• Global Bispecific Antibodies…
Global mRNA Cancer Vaccine Clinical Trials FDA Approval Insight
Global mRNA Cancer Vaccines Clinical Trials and Market Future Outlook 2024 Report Highlights:
• mRNA Cancer Vaccines In Clinical Trials: > 60 Vaccines
• Highest Phase Of Clinical Trials:…
Global Next Generation Multispecific Antibody Market Size Clinical Trials FDA Ap …
Global Multispecific Antibodies Market, Drug Sales, Price & Clinical Trials Insight 2029 Report Highlights:
• Global & Regional Market Analysis
• Global Multispecific Antibodies Market Opportunity: > USD 40…
China Pioneering The Development Of Bispecific Antibody Drug Conjugates
Global Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals and Future Market Opportunity Outlook 2029 Report:
• Report Answers Question On Why There Exists Need For Bispecific…
Rise of Bispecific Antibody Drug Conjugates With BL-B01D1 JSKN003
Rise of Bispecific Antibody Drug Conjugates With BL-B01D1 JSKN003
Global Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals and Future Market Opportunity Outlook 2029 Report:
• Report…
CD137 Clinical Trials and Market Opportunity
CD137, also known as 4-1BB, is emerging as a pivotal target in cancer immunotherapy, and ongoing clinical trials are evaluating its potential across a variety…
Future Directions in CD47 Research: Innovations and Clinical Translation
CD47, a protein that plays a critical role in immune evasion by tumor cells, has emerged as a key target in cancer research. Its ability…
Advances in Targeting CD137 for Tumor Immunotherapy
CD137 has become a central focus in the search for more effective cancer treatments, particularly in the realm of tumor immunotherapy. The receptor's role in…
The Impact of CD137 on T Cell Activation and Immunity
CD137, also referred to as 4-1BB, plays a critical role in the regulation of immune responses, particularly through its influence on T cell activation. T…
The Mechanisms of Action of Targeted Antibodies in Cancer Therapy
Understanding the mechanisms of action of targeted antibodies is crucial for appreciating their role in cancer therapy and their potential to improve patient outcomes. Targeted…
Breakthroughs In Antibody Based Targeting of Cancer Cells
Antibody-based targeting has seen significant breakthroughs in recent years, revolutionizing the way we approach cancer treatment. By leveraging the precision of antibodies to specifically target…
Clinical Trials and Developments in MCL1 Inhibitors
Clinical trials are playing a pivotal role in advancing the development of MCL1 inhibitors, shedding light on their potential to become a transformative treatment option…
MCL1 Inhibition: A Key Strategy in Cancer Treatment
Inhibition of the MCL1 protein has emerged as a key strategy in the treatment of cancer, particularly for malignancies that are resistant to conventional therapies.…
Future of MCL1 Inhibitors in Precision Medicine
The future of MCL1 inhibitors in precision medicine looks promising as these targeted therapies continue to evolve, offering a new level of specificity in cancer…
Emerging MCL1 Inhibitors Game Changer in Cancer Therapy
The emergence of MCL1 inhibitors is being hailed as a game changer in cancer therapy, particularly for cancers that have developed resistance to existing treatments.…
MCL1 Inhibitors Paving the Way for Novel Cancer Treatments
The development of MCL1 inhibitors is paving the way for a new era of cancer treatments, particularly in the context of cancers that have become…
MCL1 Inhibitors Unlocking New Potential in Cancer Research
The exploration of MCL1 inhibitors has opened up new avenues in cancer research, offering a deeper understanding of how targeted therapies can be used to…
The Potential of Multispecific Antibodies in Cancer Therapy
Multispecific antibodies represent a significant advancement in cancer therapy, offering the ability to target multiple antigens simultaneously. By engaging several targets, these engineered antibodies provide…
Bispecific Antibodies: Revolutionizing Targeted Cancer Therapy
Bispecific antibodies (BsAbs) are revolutionizing targeted cancer therapy by offering a dual-targeting approach that enhances therapeutic efficacy and addresses tumor heterogeneity. These engineered antibodies are…
Trispecific Antibodies: Pioneering Targeted Cancer Immunotherapy
Trispecific antibodies (TsAbs) are pioneering a new era in targeted cancer immunotherapy by engaging three distinct antigens simultaneously. This complex targeting strategy enhances the precision…
Novel Bispecific Antibodies for Targeted Cancer Treatment
Novel bispecific antibodies (BsAbs) are at the forefront of targeted cancer treatment, offering a dual-targeting approach that enhances therapeutic efficacy and addresses tumor heterogeneity. These…
Development and Optimization of Next-Generation TIGIT Antibodies
The development and optimization of next-generation TIGIT antibodies represent a significant advancement in cancer immunotherapy. These antibodies are designed to target the TIGIT immune checkpoint…
TIGIT Antibodies in Combination with Chemotherapy: Current Evidence and Future D …
The combination of TIGIT antibodies with chemotherapy is an emerging strategy in cancer treatment, aiming to leverage the strengths of both approaches to achieve better…
TIGIT Antibodies: Targeting Immune Suppression in the Tumor Microenvironment
TIGIT antibodies are gaining recognition for their ability to target immune suppression in the tumor microenvironment, offering a novel approach to enhancing anti-tumor immunity. The…
TIGIT Antibodies: A New Frontier in Immune Checkpoint Inhibition
TIGIT antibodies represent a new frontier in immune checkpoint inhibition, offering a novel approach to cancer immunotherapy. Immune checkpoints are regulatory pathways that maintain immune…
The Future of TIGIT Antibodies in Personalized Cancer Treatment
The future of TIGIT antibodies in personalized cancer treatment looks promising, with the potential to revolutionize the way we approach cancer therapy. Personalized medicine aims…
Comparative Effectiveness of TIGIT Antibodies and Other Checkpoint Inhibitors
The comparative effectiveness of TIGIT antibodies and other checkpoint inhibitors is a topic of significant interest in the field of cancer immunotherapy. Immune checkpoint inhibitors…
TIGIT Antibodies: A New Frontier in Immune Checkpoint Inhibition
TIGIT antibodies represent a new frontier in immune checkpoint inhibition, offering a novel approach to cancer immunotherapy. Immune checkpoints are regulatory pathways that maintain immune…
Biomarkers for Predicting Response to TIGIT Antibody Therapy
Identifying biomarkers for predicting response to TIGIT antibody therapy is crucial for optimizing treatment outcomes and personalizing cancer therapy. Biomarkers can help select patients who…
Combining TIGIT Antibodies with Other Immunotherapies for Enhanced Cancer Treatm …
Combining TIGIT antibodies with other immunotherapies has emerged as a promising strategy to enhance cancer treatment. The rationale behind this approach is based on the…
Anti TIGIT Drugs: A New Approach to Immune Checkpoint Inhibition
Anti-TIGIT drugs represent a new approach to immune checkpoint inhibition, offering a novel strategy to enhance the immune system's ability to fight cancer. Immune checkpoint…
The TIGIT Gene and Its Role in Autoimmune Diseases
The TIGIT gene and its role in autoimmune diseases have become a significant focus of research, as scientists seek to understand how this immune checkpoint…
Innovations in Immunotherapy The Rise of Anti TIGIT Antibodies
Innovations in immunotherapy have transformed the landscape of cancer treatment, offering new hope to patients who previously had limited options. Among these innovations, the rise…
Trop2 Antibodies for Personalized Cancer Treatment
Personalized cancer treatment has become a central focus in oncology, aiming to tailor therapies to the unique genetic and molecular profiles of individual patients. Trop2…
